Beta Alethine in Treating Patients With Low-Grade Lymphoma
Clinical trial NCT00007839 · UNKNOWN
Trial details
- NCT number
- NCT00007839
- Sponsor
- LifeTime Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.